Bristol-Myers Squibb Company (BMY)
Market Closed
23 Jul, 20:00
$
61. 51
+0.75
+1.2344%
$
122.85B Market Cap
- P/E Ratio
2.52% Div Yield
7.6M Volume
- Eps
$ 60.76
Previous Close 
Want to track BMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3 Bargain Stocks to Buy Now: May 2024
Since the bull market began in November 2022, growth stocks have outperformed value by a significant margin. Nevertheless, value S&P 500 sectors like financials and utilities have led over the past two months as the market has broadened out.
Investorplace | 2 years ago
Insider Trading is Good News for These Stocks
Insiders are buying these hot stocks that have ample upside for investors. The list includes pharma, entertainment, and financial stocks and Berkshire buys.
Insidertrades | 2 years ago
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Bristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy Breyanzi to treat adult patients with relapsed or refractory follicular lymphoma.
Zacks | 2 years ago
